More than 70 researchers, including CNAG, analysed genetic and clinical data from 5,000 people to investigate the genetic factors.
Researchers have discovered a window of opportunity to eliminate metastasis at an early stage, before it causes symptoms.
Discover the latest research in comparative epigenomics at our upcoming seminar with Alex de Mendoza.
The new system, developed by the Biomedical Genomics Group at CNAG, has been tested in the EU HEREDITARY Project.
CNAG joins a nationwide community committed to advancing excellence in research management.
